Inflammatory bowel disease: estimates from the global burden of disease 2017 study

Alimentary Pharmacology & Therapeutics

Fecha de publicación: 29 October 2019

DOI: https://doi.org/10.1111/apt.15542

Autores: Daniele Piovani, Silvio Danese, Laurent Peyrin‐Biroulet, Stefanos Bonovas

Background: Inflammatory bowel disease (IBD) is a significant health problem in the industrialised world, currently increasing in developing countries. Understanding the global burden of IBD is important to tackle increasing disease occurrence.